Labiana Health, S.A. (LAB.MC)
- Previous Close
3.3000 - Open
3.3000 - Bid 3.4000 x --
- Ask 3.5000 x --
- Day's Range
3.3000 - 3.5000 - 52 Week Range
1.7500 - 3.5000 - Volume
5,163 - Avg. Volume
2,299 - Market Cap (intraday)
24.552M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1600 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized, and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contract developments and manufacturing services. Labiana Health S.A. was founded in 1958 and is based in Pozuelo de Alarcón, Spain.
www.labiana.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: LAB.MC
View MorePerformance Overview: LAB.MC
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is IBEX 35... (^IBEX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LAB.MC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LAB.MC
View MoreValuation Measures
Market Cap
24.55M
Enterprise Value
55.16M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.38
Price/Book (mrq)
6.14
Enterprise Value/Revenue
0.85
Enterprise Value/EBITDA
7.08
Financial Highlights
Profitability and Income Statement
Profit Margin
0.38%
Return on Assets (ttm)
5.85%
Return on Equity (ttm)
6.92%
Revenue (ttm)
67.37M
Net Income Avi to Common (ttm)
253.45k
Diluted EPS (ttm)
-0.1600
Balance Sheet and Cash Flow
Total Cash (mrq)
6.9M
Total Debt/Equity (mrq)
363.55%
Levered Free Cash Flow (ttm)
6.88M